Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.35
-0.95 (-1.93%)
Apr 2, 2025, 1:30 PM CST

Medigen Vaccine Biologics Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-80.47-1,160-1,4751,410-674.28
Upgrade
Depreciation & Amortization
134.99130127.26112.33122.21
Upgrade
Other Amortization
1.451.170.630.220.04
Upgrade
Loss (Gain) From Sale of Assets
-0.41----19.73
Upgrade
Loss (Gain) From Sale of Investments
-1.429.6416.550.070.06
Upgrade
Stock-Based Compensation
14.1618.3175.6168.8244.66
Upgrade
Other Operating Activities
71.32-16.6619.32-0.02-2.87
Upgrade
Change in Accounts Receivable
31.0845.29445.79-635.73-4.46
Upgrade
Change in Inventory
-68.43161.1518.71-486.06-69.04
Upgrade
Change in Accounts Payable
-12.5-82.6421.7265.6319.28
Upgrade
Change in Unearned Revenue
---111.41111.41-
Upgrade
Change in Other Net Operating Assets
-49.03411.02-353.41-67.03-5.84
Upgrade
Operating Cash Flow
40.75-482.56-1,214579.89-589.97
Upgrade
Capital Expenditures
-34.3-38.69-139.17-133.63-99.25
Upgrade
Sale of Property, Plant & Equipment
0.87--12029.69
Upgrade
Sale (Purchase) of Intangibles
-0.68-2.27-1.17-1.34-6.05
Upgrade
Investment in Securities
1,050636.38-2,279-881.8-
Upgrade
Other Investing Activities
1.2974.4134.74-33.93-0.69
Upgrade
Investing Cash Flow
1,018669.83-2,285-930.69-76.3
Upgrade
Short-Term Debt Issued
---3030
Upgrade
Long-Term Debt Issued
--1,755--
Upgrade
Total Debt Issued
--1,7553030
Upgrade
Short-Term Debt Repaid
----30-60
Upgrade
Long-Term Debt Repaid
-1,740-11.78-11.56-1.93-441.76
Upgrade
Total Debt Repaid
-1,740-11.78-11.56-31.93-501.76
Upgrade
Net Debt Issued (Repaid)
-1,740-11.781,744-1.93-471.76
Upgrade
Issuance of Common Stock
3.4713.371,57955.682,404
Upgrade
Other Financing Activities
----2.582.58
Upgrade
Financing Cash Flow
-1,7361.593,32351.181,935
Upgrade
Foreign Exchange Rate Adjustments
0.1100.35-0.11-0.22
Upgrade
Net Cash Flow
-677.51188.87-175.44-299.731,269
Upgrade
Free Cash Flow
6.46-521.25-1,353446.26-689.22
Upgrade
Free Cash Flow Margin
1.07%-133.78%-370.64%13.60%-5989.55%
Upgrade
Free Cash Flow Per Share
0.02-1.59-4.181.39-2.49
Upgrade
Cash Interest Paid
7.727.327.536.0216.42
Upgrade
Levered Free Cash Flow
-81.08-164.31-744.24-288.35-601.43
Upgrade
Unlevered Free Cash Flow
-69.27-140.83-727.43-284.59-591.17
Upgrade
Change in Net Working Capital
93.85-509.29-169.58933.32175.35
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.